McKnight's April 17, 2024
Older adults are not represented adequately in clinical trials of medications for disorders that are common in the population. The legal framework to better represent them is in place, but not enough is happening to increase the number of older adults involved in research, according to a paper published on April 10 in the Journal of the American Geriatrics Society.
“Without the enrollment of older adults that are representative of clinical populations in clinical trials, clinicians will continue to be faced with uncertainty as to the safety and efficacy of new drugs for older adults,” Janice B. Schwartz, MD, a professor of medicine at University of California San Francisco, wrote in the report.
A new law mandates that clinical trial...